Claims
- 1. A rubber-stopped sterile injection container containing a medication for preventing at least some of the side effects of azaphosdhorin comprising an injectionable mesna solution having a pH value between about 7.5 and about 8.5.
- 2. The rubber-stopped sterile injection container of claim 1, wherein the mesna solution consists essentially of mesna, a complexing agent, a pH adjuster, and a preservative.
Priority Claims (1)
Number |
Date |
Country |
Kind |
42 33 842.5 |
Oct 1992 |
DEX |
|
Parent Case Info
This is a continuation of application Ser. No. 08/474,247, filed on Jun. 7, 1995, which was abandoned, which is a division of application Ser. No. 08/132,180, filed Oct. 6, 1993, now abandoned.
US Referenced Citations (1)
Number |
Name |
Date |
Kind |
4720379 |
Heyl et al. |
Jan 1988 |
|
Foreign Referenced Citations (1)
Number |
Date |
Country |
3111770 |
May 1991 |
DEX |
Non-Patent Literature Citations (4)
Entry |
Cerny et al., Bioavailability of subcutaneous Ifosfamide and feasibility of continuous outpatient application in cancer patients, Anals of Oncology, vol. I, pp. 365-368, 1990. |
Kwon et al., "Activation Mechanisms of Mafosfamide and the Role of Thiols in Cyclophosphamide Metabolism", J.Med.Chem. 1987, vol. 30, pp. 395-399. |
Leeuwenkamp, et al., Reaction Kinetics of Cisplatin and its Monoaquated Species with the Modulating Agents (Di)mesna and Thiosulphate, Eur.J.Cancer, vol. 27, No. 10, pp. 1243-1247, 1991. |
Rote Liste 1992. |
Continuations (1)
|
Number |
Date |
Country |
Parent |
474247 |
Jun 1995 |
|